Neoadjuvant Immunotherapy With Prolgolimab in Patients With Locally Advanced Microsatellite Instability/Defective Mismatch Repair Colorectal Cancer
The use of prolgolimab in locally advanced dMMR/MSI CRC is associated with high rates of pCR and cCR, allowing for further exploration of organ-sparing approaches in these patients.
Authors
- В. А. Алиев (ORCID: https://orcid.org/0000-0002-9611-6459)
- З. З. Мамедли (ORCID: https://orcid.org/0000-0002-9289-1247)
- А. М. Строганова (ORCID: https://orcid.org/0000-0002-7297-5240)
- Khasan Dzhumabaev (ORCID: https://orcid.org/0000-0001-7627-6108)
- A. V. Polynovskiy (ORCID: https://orcid.org/0000-0002-1148-8051)
- N. Ts. Drobot (ORCID: https://orcid.org/0000-0001-6566-8085)
- Olesya Kuznetsova (ORCID: https://orcid.org/0000-0001-7753-3081)
- A. A. Zagidullina (ORCID: https://orcid.org/0000-0002-6008-8492)
- A. Tryakin (ORCID: https://orcid.org/0000-0003-2245-214X)
- А. А. Анискин
- И. А. Карасев (ORCID: https://orcid.org/0000-0002-7025-970X)
- М. Yu. Fedyanin (ORCID: https://orcid.org/0000-0001-5615-7806)
- Maxim Ivanov (ORCID: https://orcid.org/0000-0002-9961-0129)
- Aleksander Prokopiev (ORCID: https://orcid.org/0009-0007-8161-4491)
Institutions
- Sechenov University (RU)
- Moscow Clinical Scientific Center (RU)
- Scientific Research Institute of Healthcare Organization and Medical Management (RU)
- National Medical Research Center of Cardiology (RU)
- Moscow City Oncology Hospital №62 (RU)
Publication Details
- Journal
- JCO Precision Oncology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1200/po-25-00602
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00